Lack of antibody induction by Histolyn-CYL, a new skin-testing reagent for histoplasmosis

Area of Science:

• Medical Mycology
• Immunology
• Infectious Diseases

Background:

• Histoplasmin skin testing is used to assess prior exposure to Histoplasma fungi.
• Histolyn-CYL is a reagent derived from the yeast phase of Histoplasma capsulatum.
• Understanding the immunological impact of skin testing is crucial for accurate diagnostic interpretation.

Purpose of the Study:

• To evaluate whether Histolyn-CYL skin testing induces a significant serological response in histoplasmin-sensitive individuals.
• To determine if skin test administration affects complement-fixing antibody titers or antibodies detectable by immunodiffusion.

Main Methods:

• A multicenter study involving 85 histoplasmin-sensitive subjects from the United States and South America.
• Administration of Histolyn-CYL yeast phase skin-test reagent.
• Collection of serum samples at the time of skin test reading and 3 weeks post-testing.
• Analysis of serum samples for complement-fixing antibodies and immunodiffusion-detected antibodies.

Main Results:

• No significant changes in complement-fixing antibody levels were observed in any subject post-skin testing.
• Antibodies detected by immunodiffusion did not show significant changes attributable to the skin test.
• The Histolyn-CYL skin test did not elicit a measurable systemic antibody response.

Conclusions:

• Histolyn-CYL skin testing is unlikely to interfere with serological assessments for histoplasmosis.
• The reagent appears to be immunologically inert in terms of inducing systemic antibody production in sensitized individuals.
• These findings support the continued use of Histolyn-CYL as a diagnostic tool without confounding serological effects.